Transcriptome network analysis reveals potential candidate genes for esophageal squamous cell carcinoma

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 3, 2012, Pages 767-773

  Ma, Zheng ^a   Guo, Wei ^a   Niu, Hui Jun ^a   Yang, Fan ^a   Wang, Ru Wen ^a   Jiang, Yao Guang ^a   Zhao, Yun Ping ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Differentially expressed genes; Esophageal squamous cell carcinoma; Network

Indexed keywords

ABC TRANSPORTER; CCNB1 PROTEIN, HUMAN; CYCLIN B1; DIFFERENTIATION ANTIGEN; LEU 13 ANTIGEN; LEU-13 ANTIGEN; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR GAMMA; STAT1 PROTEIN; STAT1 PROTEIN, HUMAN; TAP1 PROTEIN, HUMAN; TUMOR MARKER;

ARTICLE; ESOPHAGUS TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETICS; HUMAN; METABOLISM; SQUAMOUS CELL CARCINOMA;

ANTIGENS, DIFFERENTIATION; ATP-BINDING CASSETTE TRANSPORTERS; CARCINOMA, SQUAMOUS CELL; CYCLIN B1; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC ASSOCIATION STUDIES; HUMANS; RECEPTORS, RETINOIC ACID; STAT1 TRANSCRIPTION FACTOR; TUMOR MARKERS, BIOLOGICAL;

EID: 84871703757     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.3.767     Document Type: Article

References (40)

1. Ayshamgul H, Ma H, Ilyar S, et al (2011). Association of defective HLA-I expression with antigen processing machinery and their association with clinicopathological characteristics in Kazak patients with esophageal cancer. Chin Med J (Engl), 124, 341-6.
2. Brivanlou AH, Darnell JE, Jr (2002). Signal transduction and the control of gene expression. Science, 295, 813-8.
3. Chattopadhyay I, Phukan R, Singh A, et al (2009). Molecular profiling to identify molecular mechanism in esophageal cancer with familial clustering. Oncol Rep, 21, 1135-46.
4. Draghici S, Khatri P, Martins RP, et al (2003). Global functional profiling of gene expression. Genomics, 81, 98-104.
5. Draghici S, Khatri P, Tarca AL, et al (2007). A systems biology approach for pathway level analysis. Genome Res, 17, 1537-45.
6. Fumoto S, Shimokuni T, Tanimoto K, et al (2008). Selection of a novel drug-response predictor in esophageal cancer: a novel screening method using microarray and identification of IFITM1 as a potent marker gene of CDDP response. Int J Oncol, 32, 413-23.
7. Guo QM (2003). DNA microarray and cancer. Curr Opin Oncol, 15, 36-43.
8. Holmes RS, Vaughan TL (2007). Epidemiology and pathogenesis of esophageal cancer. Semin Radiat Oncol, 17, 2-9.
9. Hourihan RN, O'Sullivan GC, Morgan JG (2003). Transcriptional gene expression profiles of oesophageal adenocarcinoma and normal oesophageal tissues. Anticancer Res, 23, 161-5.
10. Ichiba M, Miyazaki Y, Kitamura S, et al (2002). Epidermal growth factor inhibits the growth of TE8 esophageal cancer cells through the activation of STAT1. J Gastroenterol, 37, 497-503.
11. Jiang C, Xuan Z, Zhao F, Zhang MQ (2007). TRED: a transcriptional regulatory element database, new entries and other development. Nucleic Acids Res, 35, D137-40.
12. Jiang Q, Wang Y, Hao Y, et al (2009). miR2Disease: a manually curated database for microRNA deregulation in human disease. Nucleic Acids Re, 37, D98-104.
13. Kanehisa M (2002). The KEGG database. Novartis Found Symp, 247, 91-101.
14. Kihara C, Tsunoda T, Tanaka T, et al (2001). Prediction of sensitivity of esophageal tumors to adjuvant chemotherapy by cDNA microarray analysis of gene-expression profiles. Cancer Res, 61, 6474-9.
15. Kuwano H, Kato H, Miyazaki T, et al (2005). Genetic alterations in esophageal cancer. Surgery today, 35, 7-18.
16. Lin J, Lin L, Thomas DG, et al (2005). Melanoma-associated antigens in esophageal adenocarcinoma: identification of novel MAGE-A10 splice variants. Clin Cancer Res, 10, 5708-16.
17. Lin PW, Lee RC, Chern MS, et al (2006). Primary malignant melanoma of the esophagus. J Chinese Med Association, 69, 334-7.
18. Lu M, Zhang Q, Deng M, et al (2008). An analysis of human microRNA and disease associations. PLoS One, 3, e3420.
19. Lu XF, Li EM, Du ZP, et al (2010). Specificity protein 1 regulates fascin expression in esophageal squamous cell carcinoma as the result of the epidermal growth factor/extracellular signal-regulated kinase signaling pathway activation. Cell Mol Life Sci, 67, 3313-29.
20. Maere S, Heymans K, Kuiper M (2005). BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics, 21, 3448-9.
21. Matsumura Y, Yashiro M, Ohira M, et al (2005). 5-Fluorouracil up-regulates interferon pathway gene expression in esophageal cancer cells. Anticancer Res, 25, 3271-8.
22. McCabe M, Dlamini Z (2005). The molecular mechanisms of oesophageal cancer. Int Immunopharmacol, 5, 1113-30.
23. Morgan G (1996). Relationship between colorectal and esophageal cancer. Dis Colon Rectum, 39, 237.
24. Nakamura T, Mohri H, Shimazaki M, et al (1997). Esophageal metastasis from prostate cancer: diagnostic use of reverse transcriptase-polymerase chain reaction for prostate-specific antigen. J Gastroenterol, 32, 236-40.
25. Nozoe T, Korenaga D, Kabashima A, et al (2002). Significance of cyclin B1 expression as an independent prognostic indicator of patients with squamous cell carcinoma of the esophagus. Clin Cancer Res, 8, 817-22.
26. Papadopoulos GL, Reczko M, Simossis VA, et al (2009). The database of experimentally supported targets: a functional update of TarBase. Nucleic Acids Res, 37, D155-8.
27. Papineni S, Chintharlapalli S, Abdelrahim M, et al (2009). Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met. Carcinogenesis, 30, 1193-201.
28. Paweletz CP, Ornstein DK, Roth MJ, et al (2000). Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. Cancer Res, 60, 6293.
29. Shannon P, Markiel A, Ozier O, et al (2003). Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res, 13, 2498-504.
30. Smyth GK (2004). Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol, 3, Article 3.
31. Song Y, Zhao C, Dong L, et al (2008). Overexpression of cyclin B1 in human esophageal squamous cell carcinoma cells induces tumor cell invasive growth and metastasis. Carcinogenesis, 29, 307-15.
32. Spies M, Dasu MR, Svrakic N, et al (2002). Gene expression analysis in burn wounds of rats. Am J Physiol Regul Integr Comp Physiol, 283, R918-30.
33. Su H, Hu N, Yang HH, et al (2011). Global gene expression profiling and validation in esophageal squamous cell carcinoma and its association with clinical phenotypes. Clin Cancer Res, 17, 2955-66.
34. Tavazoie S, Hughes JD, Campbell MJ, et al (1999). Systematic determination of genetic network architecture. Nat Genet, 22, 281-5.
35. Vaughan TL, Kiemeney L, McKnight B (1995). Colorectal cancer in patients with esophageal adenocarcinoma. Cancer Epidemiol Biomarkers Prev, 4, 93.
36. Wachi S, Yoneda K, Wu R (2005). Interactome-transcriptome analysis reveals the high centrality of genes differentially expressed in lung cancer tissues. Bioinformatics, 21, 4205-8.
37. Watanabe G, Kaganoi J, Imamura M, et al (2001). Progressionof esophageal carcinoma by loss of EGF-STAT1 pathway. Cancer J, 7, 132-9.
38. Wingender E (2008). The TRANSFAC project as an example of framework technology that supports the analysis of genomic regulation. Brief Bioinform, 9, 326-32.
39. Xiao F, Zuo Z, Cai G, et al (2009). miRecords: an integrated resource for microRNA-target interactions. Nucleic Acids Res, 37, D105-10.
40. Yang JH, Li JH, Shao P, et al (2011). starBase: a database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data. Nucleic Acids Res, 39, D202-9.